+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Left Atrial Appendage Closure Devices Market Size, Share & Trends Analysis Report by Technique (Epicardial, Endocardial), by End-use (Hospitals, Others), by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2022
  • Region: Global
  • Grand View Research
  • ID: 5681751
The global left atrial appendage closure devices market size is expected to reach a value of USD 5.7 billion by 2030, registering a CAGR of 20.5% during the forecast period. Increasing incidences of atrial fibrillation (AF) is expected to raise the left atrial appendage closure (LAAC) devices demand during the forecast period, which will further boost the market development.

The most prevalent arrhythmic condition in the world, AF affects more than 2.3 million individuals in the United States and 4.5 million in the European Union. With age, the incidence and disorder burden of AF increases, accounting for 15% of all strokes. The left atrial appendage (LAA) closure devices market has been greatly impacted by COVID-19. The pandemic prompted non-urgent operations, such as structural heart (SH) interventional surgery to be postponed or canceled, thereby, negatively impacting the market during 2020.

The COVID-19 outbreak had a temporary negative impact on product demand, significant delays in clinical trials, disrupted operations, and the market witnessed a detrimental effect on financial performance. For instance, AtriCure reported that its business was most impacted in the second, third, and fourth quarters of 2020, in terms of the decline in patients and revenue from the shelter-in-place restrictions in a majority of the countries and limitations on procedures in hospitals. However, the market witnessed growth from the third quarter of 2020, as patient procedure volume trends and availability of healthcare resources improved owing to a lift in certain restrictions.

The LAAC device industry is competitive and significantly affected by the new product introductions and other strategic activities of the industry participants. Market leaders are involved in the establishment of extensive distribution systems as well as increasingly engaged in mergers &acquisitions to capture a larger share of the market. For instance, in February 2022, Boston Scientific Corporation completed the acquisition of Baylis Medical Company Inc., a privately-held corporation that has developed the Versa Cross Transseptal Platforms including a family of sheaths, guidewires, and dilators used to support left heart access. Thus, expanded Boston Scientific Corporation’s electrophysiology and structural heart product portfolios.

Left Atrial Appendage Closure Devices Market Report Highlights

  • Endocardial dominated the technique segment of the left atrial appendage closure (LAAC) devices market in 2021. Endocardial implants are considered to be easier for using. The availability of a wide range of products also contributes to segment growth
  • The epicardial segment is expected to grow at a lucrative rate during the forecast period. Epicardial procedures possess benefits over some endocardial device features. Anticoagulation is not necessary while using epicardial devices, not even immediately after the procedure
  • The hospital segment held the largest share of over 77% in 2021. Due to the increasing popularity of LAA surgeries and the growing acceptance of LAA closure devices in hospitals, they make up the largest end-use segment for the left atrial appendage closure devices
  • Asia Pacific region is anticipated to register rapid growth in coming years owing to the presence of high unmet needs coupled with increasing patient awareness levels and improving healthcare infrastructure
  • Growing R&D investments by the key companies and geographic expansion, as well as an increase in product portfolios, are the factors expected to contribute to the market growth. In August 2021, Abbott has received U.S. FDA approval for its Amplatzer Amulet LAA Occluder to treat individuals with atrial fibrillation

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates & Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research:
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Abbreviations
1.10 Objectives
1.10.1 Objective 1:
1.10.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Outlook
Chapter 3 Left Atrial Appendage Closure (LAAC) Devices Market Variables Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraints Analysis
3.4 Industry Analysis - Porter’s
3.5 Left Atrial Appendage Closure (LAAC) Devices Market- PESTLE Analysis
3.6 Regulatory Framework
3.7 Technology Overview
3.8 Estimated Pricing Analysis
3.9 Product Pipeline Analysis
3.10 Emerging supporting technologies for LAAC procedures
3.11 Covid-19 Impact Analysis
3.11.1 Current And Future Impact Analysis
3.11.2 Impact Of Covid-19 On Market Players
Chapter 4 Competitive Landscape
4.1 Market participation categorization
4.2 Public Companies
4.2.1 Company Market Position Analysis
4.2.2 Company Market Share Analysis
4.2.3 Synergy Analysis: Major Deals & Strategic Alliances
Chapter 5 Left Atrial Appendage Closure (LAAC) Devices Market: Technique Analysis
5.1 Technique Business Analysis
5.1.1 Epicardial
5.1.1.1 Epicardial market estimates and forecasts, 2017 - 2030 (USD Million)
5.1.2 Endocardial
5.1.2.1 Endocardial market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 Left Atrial Appendage Closure (LAAC) Devices Market: End-use Analysis
6.1 End-use Business Analysis
6.1.1 Hospitals
6.1.1.1 Hospitals market estimates and forecasts, 2017 - 2030 (USD Million)
6.1.2 Others
6.1.2.1 Others Industry market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 7 Left Atrial Appendage Closure (LAAC) Devices Market: Regional Market Analysis, Technique, and End-use 2017 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021& 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030
7.5.1 North America
7.5.1.1 North America Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts by countries, 2017 - 2030 (USD Million)
7.5.1.2 U.S.
7.5.1.2.1 U.S. Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.1.3 Canada
7.5.1.3.1 Canada Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.2 Europe
7.5.2.1 Europe Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts by countries, 2017 - 2030 (USD Million)
7.5.2.2 UK
7.5.2.2.1 UK Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.2.3 Germany
7.5.2.3.1 Germany Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.2.4 France
7.5.2.4.1 France Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.2.5 Italy
7.5.2.5.1 Italy Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.2.6 Spain
7.5.2.6.1 Spain Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3 Asia Pacific
7.5.3.1 Asia Pacific Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3.2 Japan
7.5.3.2.1 Japan Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3.3 China
7.5.3.3.1 China Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3.4 India
7.5.3.4.1 India Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.3.5 Australia
7.5.3.5.1 Australia Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.4 Latin America
7.5.4.1 Latin America Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.4.2 Brazil
7.5.4.2.1 Brazil Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.4.3 Argentina
7.5.4.3.1 Argentina Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.5 MEA
7.5.5.1 MEA Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts by countries, 2017 - 2030 (USD Million)
7.5.5.2 South Africa
7.5.5.2.1 South Africa Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
7.5.5.3 Saudi Arabia
7.5.5.3.1 Saudi Arabia Left Atrial Appendage Closure (LAAC) Devices Market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Boston Scientific Corporation
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiatives
8.2 Abbott
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiatives
8.3 AtriCureInc.
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiatives
8.4 Life tech Scientific
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiatives
8.5 Cardia, Inc.
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Product Benchmarking
8.5.4 Strategic Initiatives
8.6 Lepu Medical Technology (Beijing) Co. Ltd.
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.6.4 Strategic Initiatives
8.7 Johnson & Johnson (Biosense Webster, Inc.)
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.7.4 Strategic Initiatives
List of Tables
Table 1 List of primary sources
TABLE 2 List of secondary sources
TABLE 3 North America Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 4 North America Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 5 U.S. Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 6 U.S. Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 7 Canada Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 8 Canada Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 9 Europe Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 10 Europe Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 11 UK Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 12 UK Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 13 Germany Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 14 Germany Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 15 France Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 16 France Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 17 Italy Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 18 Italy Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 19 Spain Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 20 Spain Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 21 Asia Pacific Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 22 Asia Pacific Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 23 Japan Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 24 Japan Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 25 China Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 26 China Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 27 India Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 28 India Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 29 Australia Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 30 Australia Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 31 Latin America Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 32 Latin America Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 33 Brazil Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 34 Brazil Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 35 Argentina Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 36 Argentina Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 37 MEA Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 38 MEA Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 39 South Africa Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 40 South Africa Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
TABLE 41 Saudi Arabia Left Atrial Appendage Closure (LAAC) Devices Market, by Technique, 2017-2030 (USD Million)
TABLE 42 Saudi Arabia Left Atrial Appendage Closure (LAAC) Devices Market, by End-Use, 2017-2030 (USD Million)
List of Figures
Fig. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic, and technological)
FIG. 8 Left Atrial Appendage Closure (LAAC) Devices Porter’s Analysis
FIG. 9 Left Atrial Appendage Closure (LAAC) Devices market, Technique outlook key takeaways
FIG. 10 Left Atrial Appendage Closure (LAAC) Devices market: Technique movement analysis
FIG. 11 Global Epicardial market, 2017-2030 (USD Million)
FIG. 12 Global Endocardial market, 2017-2030 (USD Million)
FIG. 13 Left Atrial Appendage Closure (LAAC) Devices market, End-Use outlook key takeaways
FIG. 14 Left Atrial Appendage Closure (LAAC) Devices market: End-use movement analysis
FIG. 15 Global hospitals market, 2017-2030 (USD Million)
FIG. 16 Global others market, 2017-2030 (USD Million)
FIG. 17 Regional market: Key takeaways
FIG. 18 Regional outlook, 2021& 2030
FIG. 19 North America Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 20 U.S. Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 21 Canada Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 22 Europe Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 23 UK Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 24 Germany Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 25 France Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 26 Italy Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 27 Spain Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 28 Asia Pacific Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 29 Japan Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 30 China Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 31 India Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 32 Australia Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 33 Latin America Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 34 Brazil Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 35Argentina Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 36 MEA Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 37 South Africa Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 38 Saudi Arabia Left Atrial Appendage Closure (LAAC) Devices market, 2017-2030 (USD Million)
FIG. 39 Strategy frame work
FIG. 40 Participant categorization

Companies Mentioned

  • Boston Scientific Corporation
  • Abbott
  • Atricureinc.
  • Life Tech Scientific
  • Cardia, Inc.
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Johnson & Johnson (Biosense Webster, Inc.)

Methodology

Loading
LOADING...

Table Information